Table 2.
Occurrence of cardiovascular disease and risk of poor health-related quality of life (HRQoL) assessed with European Organisation for Research and Treatment of Cancer QLQ-C30 and presented as OR with 95% CI
| Cardiovascular diseases† |
||||
|---|---|---|---|---|
| None 3552 (72) |
At least one 1358 (28) |
|||
| HRQoL aspects* | Number (%) | Number (%) | OR (95% CI)‡ | |
| Poor global quality of life | 414 (12) | Reference | 250 (18) | 1.45 (1.06 to 1.97) |
| Poor physical function | 946 (27) | Reference | 675 (50) | 1.77 (1.36 to 2.32) |
| Poor role function | 325 (9) | Reference | 208 (15) | 1.91 (0.97 to 3.76) |
| Poor emotional function | 587 (17) | Reference | 250 (18) | 0.94 (0.70 to 1.26) |
| Symptomatic fatigue | 651 (18) | Reference | 343 (25) | 1.41 (1.07 to 1.86) |
| Symptomatic dyspnoea | 1040 (29) | Reference | 628 (46) | 1.69 (1.36 to 2.09) |
Frequency weighted for age and sex to match the national distribution in Sweden.
*Poor or symptomatic: At least one response of ‘quite a bit’ or ‘very much’ on an item within a scale (physical, role and emotional function, fatigue and dyspnoea) or at least one response of 1–4 on one of the items in the Global quality-of-life scale.
†Cardiovascular disease: Angina, atrial fibrillation, heart failure, hypertension or earlier myocardial infarction.
‡Adjusted for age, sex, education, comorbidity, tobacco smoking and physical activity.